Industry Sponsored Research Agreements Frank Sellke, MD Division of Cardiothoracic Surgery Brown Medical School Providence RI AATS Grant Course 2011.

Slides:

Advertisements

Similar presentations

VCOM Conflict of Interest Policy Overview of Financial Conflict of Interest Related to Research December 4, 2013.

Advertisements

Financial Conflict of Interest July 2012 rev

Conflict of Interest (COI) Objectives: Provide an overview of financial conflict of interest (FCOI) related to research activities at Gillette Describe.

1 UMass Dartmouth Conflicts of Interest Policies UMass Dartmouth Liz Rodriguez February 17, 2011.

Managing Conflicts of Interest © ACCME.

JUNE 19, 2012 PAUL MURPHY, JD DIRECTOR, RESEARCH ADMINISTRATION SERIES 2, SESSION 7 APPLICANTS & ADMINISTRATORS PREAWARD LUNCHEON SERIES Public Health.

Financial Conflict of Interest (FCOI) Updates Office of Sponsored Programs April 2014.

NIH FINANCIAL CONFLICT OF INTEREST REGULATIONS – 2012 Office of Sponsored Programs Research & Graduate Studies.

RESEARCH CONFLICTS OF INTEREST Steven J. Norris, PhD Greer Professor and Vice Chair for Research Department of Pathology and Laboratory Medicine Chair,

Technology and Economic Development Intellectual Property Issues in Research Jim Baker Director Office of Technology and Economic Development

This tutorial reviews the main requirements of and the responsibilities for compliance with the 2011 revised Federal regulation on Financial Conflict of.

IP Issues in Research Jim Baker, Executive Director Innovation, and Industry Engagement.

Stretch Your TTO’s Budget Michael Rondelli, J.D., M.B.A Director, Technology Transfer Office San Diego State University Research Foundation.

Industry – University Transactions: Rights to Future Intellectual Property Varda N. Main Director, Technology Licensing Rochester Institute of Technology.

Conflicts of Interest in Research: Policies and Regulations Marie Barron, M.A., COI Program Specialist Rick Lyons, M.D., Ph.D., COI Committee C Chair.

OPIC IP Roundtable 21 November 2007 Intellectual Property Policy at the University of Cambridge Ian Leslie Pro-Vice-Chancellor for Research

Grants and Industry Engagement Issues Advantages and Disadvantages

What we ask in a ROI What it is? Is it related to another invention? Who contributed to making the invention? Who paid for the research? When invention.

Starting a Company from Research at the UW James A. Severson, Ph.D. Vice Provost, Intellectual Property and Technology Transfer January 30, 2007.

February 25, 2014 SERIES 4, SESSION 2 OF AAPLS APPLICANTS & ADMINISTRATORS PREAWARD LUNCHEON SERIES Material Transfer and Confidentiality Agreements.

Successfully Negotiating and Administering Industry Projects John Hanold Senior Associate Director Office of Sponsored Programs Barbara Suchanec Director.

Promoting Objectivity in Research by Managing, Reducing, or Eliminating Conflicts of Interest UT HOP UT HOP The University of Texas at Austin.

Technology Transfer at Rice

Contracts: Negotiations and Key Elements Belinda Vandersluis Operations Director, NCIC CTG.

THE ORTHOPAEDIC SURGEON’S RELATIONSHIPS WITH INDUSTRY AAOS ETHICS COMMITTEE Kenneth C. Thomas, MD 1.

INDUSTRY SPONSORED RESEARCH David Erem University of Kentucky Office of Sponsored Programs.

North Shore – LIJ Health System PREP Workshop #4: How to Report and Manage External Interests (COIs) Electronically.

Commercialisation at Griffith Dorina Caccamo Manager, Contracts and Administration Griffith Enterprise Value through.

A Dual Role Principal (Rector) of Heriot-Watt University Chair of the regional economic development company.

10/19/2011F. B. Bramwell1.  Thanks to conversations with: ◦ HU Office of General Counsel  John Gloster  Dan McCabe ◦ University of Kentucky Intellectual.

NOVEMBER 13, 2012 SERIES 2, SESSION XI OF APPLICANTS & ADMINISTRATORS PREAWARD LUNCHEON SERIES Research Sponsored by Industry – Putting an Agreement in.

Organizing a Technology Licensing Office (TLO) Jon Sandelin Senior Associate Emeritus

What should you know about Intellectual Property? Katharine Ku Office of Technology Licensing.

Research Conflicts of Interest: Identifying and Minimizing COI from the Perspective of Faculty July 30, 2009 PonJola Coney, MD Senior Associate Dean for.

Business Development Team. Speakers Chris Mountford Business Development Executive Alexandra Cassidy Commercial Relations Executive.

NIH Technology Transfer and Ethics Pat Lake, Deputy Director Extramural Technology Transfer NIDDK, NIH FLC – Mid Atlantic Regional Meeting, Rocky Gap,

Introduction to the Offices of Biotechnology & Business Development John L. Harb Director, Office of Biotechnology __________________________________ October.

03/10/2008 Terese Rakow, PhD. Postdoctoral Career Development Course March 10, 2008.

Policies Promoting IP Development in Universities and Higher Institutions of Learning In Africa OGADA Tom WIPO National Workshop on Intellectual Property.

SF Coordinating Center Multicenter Trials Industry-sponored Trials Steve Cummings, MD Director, SF Coordinating Center.

University of Pittsburgh Presentation to Schools of Pharmacy and Nursing: Consulting Requirements within the Industry Relationship Policy Presented by.

Partners Conflict of Interest Policy and Reporting October 11, 2012.

Copyright © Harvard Medical School. All Rights Reserved. Outside Activity Report: What Do I Need to Report?

General Guidelines for Institutional IP Policies: What Should be There Franco G. Teves, Ph.D., Dipl. PAM Director of Research MSU-IIT.

Stanford Policy – Faculty ◦ Mission: Promote public good by transferring knowledge  Consulting  Technologies arising from research These activities can.

Policy on the Management of Intellectual Property in Technology Transfer Activities at CERN CERN/FC/5434/RA Technology Transfer Network Meeting – 10 th.

Who, what, where and when. UCC Office of Technology Transfer.

Industrial Partnerships in BME Design 2007 BME idea Meeting Jay R. Goldberg, PhD, PE Marquette University Mary Beth Privitera, M. Design University of.

Lecture 27 Intellectual Property. Intellectual Property simply defined is any form of knowledge or expression created with one's intellect. It includes.

Financial Conflict of Interest January  Financial Conflict of Interest regulation 42 CFR 50 Subpart F promotes objectivity in research by establishing.

FDA Regulatory and Compliance Symposium Industry Collaboration & Interactions with Health Professionals: Can Conflicts of Interest be Properly Managed?

Durban, South Africa January 29 to 31, 2013 Topic 13: The Effective Administrative Process for the Grant of Compulsory Licenses Regional Seminar for Certain.

Review of Research-Related Agreements Between Academic Institutions and Other Entities. Manoja Ratnayake Lecamwasam, PhD Intellectual Property and Innovation.

Research Strategy: Approach Frank Sellke, MD Division of Cardiothoracic Surgery Brown Medical School Providence RI AATS Grant Course 2011.

1 The Implementation of Fair Market Value What can we learn from recent enforcement actions? Debjit Ghosh Life Sciences Advisory Services Huron Consulting.

OTC FELLOWS PROGRAM INFORMATION SESSION Fall 2016.

Technology Transfer Office

Patricia M. Alt, Ph.D. Dept. of Health Science Towson University

Lecture 28 Intellectual Property(Cont’d)

How to Apply for and Receive Industry Funding for Investigator Sponsored Research Chuck Simonton MD, FACC, FSCAI Chief Medical Officer Abbott Vascular.

Protecting and exploiting research results at Newcastle University Geraint Lewis – Business Development Manager, Research and Enterprise Services

UCR PRO Reviewer Placemat

Conflict of Interest Disclosure <First Name> <Last Name>, <Degree>

Has no real or apparent conflicts of interest to report.

Disclosure of conflicts of interest – explanation

Disclosures The project was funded from the following sources:

Disclosure of conflicts of interest

Disclosure of conflicts of interest

Conflict of Interest Disclosure <First Name> <Last Name>, <Degree>

Presentation transcript:

Industry Sponsored Research Agreements Frank Sellke, MD Division of Cardiothoracic Surgery Brown Medical School Providence RI AATS Grant Course 2011

Industry Sponsored Research Agreements Disclosures: Steering Committee for Novonordisk DSMB: Cubist Pharmaceutical CSL Behering: Advisory Board Chairman, DSMB CT Surgery Network, National Institutes of Health National Institutes of Health (RO1 HL46716, RO1 HL 69024) to FWS Royalties from Elsevier Publishing

Why do Research for Industry?

Money is money, regardless of from where it comes NIH funding and $ from other sources is decreasing Industry often is aware of what is important clinically and in the market place. A direct link to patients. There is often a lot of funding available if you have something to offer, especially if you have a niche. The funded research often ties in with your clinical activity and interests. You can generally keep the left over money. You get to travel to very interesting places and speak with interesting and famous people.

Industry Sponsored Research A company wants to contract with you to do work. The company knows what they want to demonstrate. It is probably in an area in which you have an interest or some niche ability. Don’t be afraid to ask for enough money to cover all costs, and then some. When you negotiate, consider IDC to institution. Generally do not ask for salary support, especially in clinically related research.

Office of Technology Development: ISRA Safeguards researchers’ ability to publish the results of their research in accordance with academic custom Is limited in duration and tied to a specific research plan that is generated by the principal investigator and approved by OTD staff Negotiates who owns the results of the sponsored research and all associated intellectual property (IP), e.g., patents, copyrights and know-how

Office of Technology Development: ISRA Generally grants the company a time-limited option to negotiate licenses to the sponsored IP on usual and customary terms (i.e., in exchange for fair market value and with appropriate commercial diligence, including as regards global access to medical technologies) – no perpetual rights, ‘sweetheart’ deals or ability to suppress technology Offers no guaranteed results or other ‘deliverables’ – the research and any resulting IP are provided to the company on an ‘as is’ basis. Reserves the rights of researchers at the institution and elsewhere to use any sponsored IP for educational and not- for-profit research use.

Why Avoid Doing Research for Industry?

Why Not do Research for Industry? The money is considered tainted. It distracts from NIH funded and real basic science or clinical investigation. There is a temptation for you to give the Company what they want, or you are perceived as such. Promotion committees consider it less than NIH grants

How to get started Develop a technique or expertise in a certain area: Aortic surgery, Myocardial protection, Bleeding and transfusion therapy, Mitral valve repair, etc. Publish and give presentations at National Meetings. Speak up at National Meetings. Speak with companies: Ask if they would sponsor your research. If you are good, They will come.

Caution If you get paid for the research, often you cannot publish it. Consult your University or Hospital Guidelines Need to disclose relationships Keep things in perspective Make sure there is no limitation or restrictions on publication or presentation of results Don’t let industry control your academic career Don’t bias the results or give limited results to support what the Company wants to hear.

Questions?